FY19 Report – Is The API (ASX:API) Share Price A Buy?
Jaz Harrison
October 24, 2019
Australian Pharmaceutical Industries (ASX:API) has released its FY19 result to
Australian Pharmaceutical Industries Ltd (ASX:API) is the pharmacy company behind Priceline, ClearSkincare, Soul Pattinson Chemist and much more. The Melbourne-based company is more than 100 years old and operates more than 500 chemists and hundreds more are included in its member network. API is part-owned by Washington H. Soul Pattinson (ASX: SOL).
Australian Pharmaceutical Industries (ASX:API) has released its FY19 result to
Low interest rates have made it impossible to generate a
Zip Co Ltd (ASX:Z1P) and Bubs Australia Ltd (ASX:BUB) just
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Is Australian Pharmaceutical Industries Ltd (ASX:API) a good dividend share
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open lower today,
Sigma Healthcare Ltd (ASX:SIG) shares jumped nearly 5% after it
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX: XAO),
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
